USANA Health Sciences, Inc.
USNA
$27.18
$0.080.30%
NYSE
12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
---|---|---|---|---|---|
Net Income | 4.45M | 10.61M | 10.43M | 16.54M | 16.77M |
Total Depreciation and Amortization | 5.88M | 5.56M | 5.70M | 5.08M | 4.87M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 948.00K | 4.77M | -3.54M | 7.56M | 4.60M |
Change in Net Operating Assets | -5.50M | 8.59M | -4.60M | -11.49M | -218.00K |
Cash from Operations | 5.79M | 29.53M | 7.99M | 17.68M | 26.02M |
Capital Expenditure | -1.80M | -2.40M | -2.67M | -3.20M | -7.32M |
Sale of Property, Plant, and Equipment | 0.00 | 61.00K | 0.00 | 3.00K | 2.00K |
Cash Acquisitions | -203.34M | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00 | 0.00 | 1.13M | -870.00K | 0.00 |
Cash from Investing | -205.14M | -2.34M | -1.55M | -4.07M | -7.32M |
Total Debt Issued | 23.00M | -2.00K | 154.00K | 537.00K | 792.00K |
Total Debt Repaid | 6.00K | 3.00K | -1.48M | -- | 0.00 |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -74.00K | -79.00K | -31.00K | -12.48M | -134.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | 0.00 |
Cash from Financing | 22.93M | -78.00K | -1.35M | -11.95M | 658.00K |
Foreign Exchange rate Adjustments | -6.81M | 5.45M | -1.02M | -3.81M | 4.06M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -183.23M | 32.57M | 4.07M | -2.14M | 23.42M |